Protein detail

LRP2

Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin)

Protein symbol
LRP2
UniProt ID
EVMP score
0.25
Frequency
1
Transmembrane count
1
Protein classification
Disease related genesHuman disease related genesMetabolic proteinsPlasma proteinsPotential drug targetsPredicted intracellular proteinsPredicted membrane proteinsTransporters
Basic Information
Protein Names
Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin)
Protein Class
Disease related genesHuman disease related genesMetabolic proteinsPlasma proteinsPotential drug targetsPredicted intracellular proteinsPredicted membrane proteinsTransporters
Protein Function
  • Transporters
  • Predicted intracellular proteins
  • Potential drug targets
  • Disease related genes
  • Human disease related genes:Congenital malformations:Other congenital malformations
Transmembrane
4424..4446; Helical
Transmembrane Count
1
Entrez Gene Symbol
Gene Synonym
DBSgp330
Gene Description
LDL receptor related protein 2
Chromosome
2
Position
169127109-169362534
Frequency
1
EVMP Score
0.25
Fluorescence & Localization
Tissue SpecificbrainCell SpecificAdrenal cortex cellsBlood Cell Specificnon-classical monocyte
Function & Pathway
Protein Function
  • Transporters
  • Predicted intracellular proteins
  • Potential drug targets
  • Disease related genes
  • Human disease related genes:Congenital malformations:Other congenital malformations
Mediation Categories
Adhesion and uptake mediationFusion and delivery mediationMetabolism mediationReceptor-signaling mediation
Relations & Evidence

Enzyme-Mediated Modification

0 records.

Ligand-Receptor Signaling

57 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
receptor_regulatorreceptor_regulatorOmniPathYesNoNoYesNo
growth_factor_binderligand_regulatorGO_IntercellYesNoNoYesNo
ligand_regulatorligand_regulatorOmniPathYesNoNoYesNo
cell_adhesioncell_adhesionCellinkerYesYesNoYesNo
matrix_adhesionmatrix_adhesionCellinkerNoYesNoYesNo
adhesionadhesionOmniPathYesYesNoYesNo
cell_adhesioncell_adhesionOmniPathYesYesNoYesNo
matrix_adhesionmatrix_adhesionOmniPathNoYesNoYesNo
transmembranetransmembraneUniProt_locationNoNoNoYesNo
transmembranetransmembraneUniProt_topologyNoNoNoYesNo
Page 3 of 6PreviousNext

Regulatory Interaction Network

5 records.

Source Protein SymbolSource UniProt IDTarget Protein SymbolTarget UniProt IDIs DirectedIs StimulationIs InhibitionDatabaseReferences
LRP2P98164SHHQ15465YesYesNoWangSignaLink3SignaLink3:11964399SignaLink3:23331499
CLUSP10909LRP2P98164YesYesNoSIGNORHPRDHINTBioGRIDSPIKE_LCBioGRID:7768901HPRD:7768901HINT:7768901BioGRID:17260971HINT:9228033HINT:17260971SPIKE_LC:16713569SIGNOR:32332780
MMP2P08253LRP2P98164YesYesNoSIGNORSIGNOR:28659595
TIMP2P16035LRP2P98164YesYesNoSIGNORSIGNOR:28659595
LRP2P98164PTC1Q13635YesYesNoSIGNORSIGNOR:26872844

Protein Complex Composition

2 records.

Component NameComponent Gene SymbolsComponent UniProt IDStoichiometryDatabaseDatabase IDsReferences
NLRP2 inflammasomeCARD8CASP1NLRP2PYCARDP29466Q9NX02Q9ULZ3Q9Y2G20:0:0:0CORUMCORUM:632415030775
LRP2P981642PDBPDB:9cwm

Isolation & Detection Technology

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
PRotein Organic Solvent Precipitation;Differential UltracentrifugationMass spectrometry132384937
Sequence, Structure & Domains

Sequences

Length
4,655
Mass
521,958
Sequence
MDRGPAAVACTLLLALVACLAPASGQECDSAHFRCGSGHCIPADWRCDGTKDCSDDADEIGCAVVTCQQGYFKCQSEGQCIPNSWVCDQDQDCDDGSDERQDCSQSTCSSHQITCSNGQCIPSEYRCDHVRDCPDGADENDCQYPTCEQLTCDNGACYNTSQKCDWKVDCRDSSDEINCTEICLHNEFSCGNGECIPRAYVCDHDNDCQDGSDEHACNYPTCGGYQFTCPSGRCIYQNWVCDGEDDCKDNGDEDGCESGPHDVHKCSPREWSCPESGRCISIYKVCDGILDCPGREDENNTSTGKYCSMTLCSALNCQYQCHETPYGGACFCPPGYIINHNDSRTCVEFDDCQIWGICDQKCESRPGRHLCHCEEGYILERGQYCKANDSFGEASIIFSNGRDLLIGDIHGRSFRILVESQNRGVAVGVAFHYHLQRVFWTDTVQNKVFSVDINGLNIQEVLNVSVETPENLAVDWVNNKIYLVETKVNRIDMVNLDGSYRVTLITENLGHPRGIAVDPTVGYLFFSDWESLSGEPKLERAFMDGSNRKDLVKTKLGWPAGVTLDMISKRVYWVDSRFDYIETVTYDGIQRKTVVHGGSLIPHPFGVSLFEGQVFFTDWTKMAVLKANKFTETNPQVYYQASLRPYGVTVYHSLRQPYATNPCKDNNGGCEQVCVLSHRTDNDGLGFRCKCTFGFQLDTDERHCIAVQNFLIFSSQVAIRGIPFTLSTQEDVMVPVSGNPSFFVGIDFDAQDSTIFFSDMSKHMIFKQKIDGTGREILAANRVENVESLAFDWISKNLYWTDSHYKSISVMRLADKTRRTVVQYLNNPRSVVVHPFAGYLFFTDWFRPAKIMRAWSDGSHLLPVINTTLGWPNGLAIDWAASRLYWVDAYFDKIEHSTFDGLDRRRLGHIEQMTHPFGLAIFGEHLFFTDWRLGAIIRVRKADGGEMTVIRSGIAYILHLKSYDVNIQTGSNACNQPTHPNGDCSHFCFPVPNFQRVCGCPYGMRLASNHLTCEGDPTNEPPTEQCGLFSFPCKNGRCVPNYYLCDGVDDCHDNSDEQLCGTLNNTCSSSAFTCGHGECIPAHWRCDKRNDCVDGSDEHNCPTHAPASCLDTQYTCDNHQCISKNWVCDTDNDCGDGSDEKNCNSTETCQPSQFNCPNHRCIDLSFVCDGDKDCVDGSDEVGCVLNCTASQFKCASGDKCIGVTNRCDGVFDCSDNSDEAGCPTRPPGMCHSDEFQCQEDGICIPNFWECDGHPDCLYGSDEHNACVPKTCPSSYFHCDNGNCIHRAWLCDRDNDCGDMSDEKDCPTQPFRCPSWQWQCLGHNICVNLSVVCDGIFDCPNGTDESPLCNGNSCSDFNGGCTHECVQEPFGAKCLCPLGFLLANDSKTCEDIDECDILGSCSQHCYNMRGSFRCSCDTGYMLESDGRTCKVTASESLLLLVASQNKIIADSVTSQVHNIYSLVENGSYIVAVDFDSISGRIFWSDATQGKTWSAFQNGTDRRVVFDSSIILTETIAIDWVGRNLYWTDYALETIEVSKIDGSHRTVLISKNLTNPRGLALDPRMNEHLLFWSDWGHHPRIERASMDGSMRTVIVQDKIFWPCGLTIDYPNRLLYFMDSYLDYMDFCDYNGHHRRQVIASDLIIRHPYALTLFEDSVYWTDRATRRVMRANKWHGGNQSVVMYNIQWPLGIVAVHPSKQPNSVNPCAFSRCSHLCLLSSQGPHFYSCVCPSGWSLSPDLLNCLRDDQPFLITVRQHIIFGISLNPEVKSNDAMVPIAGIQNGLDVEFDDAEQYIYWVENPGEIHRVKTDGTNRTVFASISMVGPSMNLALDWISRNLYSTNPRTQSIEVLTLHGDIRYRKTLIANDGTALGVGFPIGITVDPARGKLYWSDQGTDSGVPAKIASANMDGTSVKTLFTGNLEHLECVTLDIEEQKLYWAVTGRGVIERGNVDGTDRMILVHQLSHPWGIAVHDSFLYYTDEQYEVIERVDKATGANKIVLRDNVPNLRGLQVYHRRNAAESSNGCSNNMNACQQICLPVPGGLFSCACATGFKLNPDNRSCSPYNSFIVVSMLSAIRGFSLELSDHSETMVPVAGQGRNALHVDVDVSSGFIYWCDFSSSVASDNAIRRIKPDGSSLMNIVTHGIGENGVRGIAVDWVAGNLYFTNAFVSETLIEVLRINTTYRRVLLKVTVDMPRHIVVDPKNRYLFWADYGQRPKIERSFLDCTNRTVLVSEGIVTPRGLAVDRSDGYVYWVDDSLDIIARIRINGENSEVIRYGSRYPTPYGITVFENSIIWVDRNLKKIFQASKEPENTEPPTVIRDNINWLRDVTIFDKQVQPRSPAEVNNNPCLENNGGCSHLCFALPGLHTPKCDCAFGTLQSDGKNCAISTENFLIFALSNSLRSLHLDPENHSPPFQTINVERTVMSLDYDSVSDRIYFTQNLASGVGQISYATLSSGIHTPTVIASGIGTADGIAFDWITRRIYYSDYLNQMINSMAEDGSNRTVIARVPKPRAIVLDPCQGYLYWADWDTHAKIERATLGGNFRVPIVNSSLVMPSGLTLDYEEDLLYWVDASLQRIERSTLTGVDREVIVNAAVHAFGLTLYGQYIYWTDLYTQRIYRANKYDGSGQIAMTTNLLSQPRGINTVVKNQKQQCNNPCEQFNGGCSHICAPGPNGAECQCPHEGNWYLANNRKHCIVDNGERCGASSFTCSNGRCISEEWKCDNDNDCGDGSDEMESVCALHTCSPTAFTCANGRCVQYSYRCDYYNDCGDGSDEAGCLFRDCNATTEFMCNNRRCIPREFICNGVDNCHDNNTSDEKNCPDRTCQSGYTKCHNSNICIPRVYLCDGDNDCGDNSDENPTYCTTHTCSSSEFQCASGRCIPQHWYCDQETDCFDASDEPASCGHSERTCLADEFKCDGGRCIPSEWICDGDNDCGDMSDEDKRHQCQNQNCSDSEFLCVNDRPPDRRCIPQSWVCDGDVDCTDGYDENQNCTRRTCSENEFTCGYGLCIPKIFRCDRHNDCGDYSDERGCLYQTCQQNQFTCQNGRCISKTFVCDEDNDCGDGSDELMHLCHTPEPTCPPHEFKCDNGRCIEMMKLCNHLDDCLDNSDEKGCGINECHDPSISGCDHNCTDTLTSFYCSCRPGYKLMSDKRTCVDIDECTEMPFVCSQKCENVIGSYICKCAPGYLREPDGKTCRQNSNIEPYLIFSNRYYLRNLTIDGYFYSLILEGLDNVVALDFDRVEKRLYWIDTQRQVIERMFLNKTNKETIINHRLPAAESLAVDWVSRKLYWLDARLDGLFVSDLNGGHRRMLAQHCVDANNTFCFDNPRGLALHPQYGYLYWADWGHRAYIGRVGMDGTNKSVIISTKLEWPNGITIDYTNDLLYWADAHLGYIEYSDLEGHHRHTVYDGALPHPFAITIFEDTIYWTDWNTRTVEKGNKYDGSNRQTLVNTTHRPFDIHVYHPYRQPIVSNPCGTNNGGCSHLCLIKPGGKGFTCECPDDFRTLQLSGSTYCMPMCSSTQFLCANNEKCIPIWWKCDGQKDCSDGSDELALCPQRFCRLGQFQCSDGNCTSPQTLCNAHQNCPDGSDEDRLLCENHHCDSNEWQCANKRCIPESWQCDTFNDCEDNSDEDSSHCASRTCRPGQFRCANGRCIPQAWKCDVDNDCGDHSDEPIEECMSSAHLCDNFTEFSCKTNYRCIPKWAVCNGVDDCRDNSDEQGCEERTCHPVGDFRCKNHHCIPLRWQCDGQNDCGDNSDEENCAPRECTESEFRCVNQQCIPSRWICDHYNDCGDNSDERDCEMRTCHPEYFQCTSGHCVHSELKCDGSADCLDASDEADCPTRFPDGAYCQATMFECKNHVCIPPYWKCDGDDDCGDGSDEELHLCLDVPCNSPNRFRCDNNRCIYSHEVCNGVDDCGDGTDETEEHCRKPTPKPCTEYEYKCGNGHCIPHDNVCDDADDCGDWSDELGCNKGKERTCAENICEQNCTQLNEGGFICSCTAGFETNVFDRTSCLDINECEQFGTCPQHCRNTKGSYECVCADGFTSMSDRPGKRCAAEGSSPLLLLPDNVRIRKYNLSSERFSEYLQDEEYIQAVDYDWDPKDIGLSVVYYTVRGEGSRFGAIKRAYIPNFESGRNNLVQEVDLKLKYVMQPDGIAVDWVGRHIYWSDVKNKRIEVAKLDGRYRKWLISTDLDQPAAIAVNPKLGLMFWTDWGKEPKIESAWMNGEDRNILVFEDLGWPTGLSIDYLNNDRIYWSDFKEDVIETIKYDGTDRRVIAKEAMNPYSLDIFEDQLYWISKEKGEVWKQNKFGQGKKEKTLVVNPWLTQVRIFHQLRYNKSVPNLCKQICSHLCLLRPGGYSCACPQGSSFIEGSTTECDAAIELPINLPPPCRCMHGGNCYFDETDLPKCKCPSGYTGKYCEMAFSKGISPGTTAVAVLLTILLIVVIGALAIAGFFHYRRTGSLLPALPKLPSLSSLVKPSENGNGVTFRSGADLNMDIGVSGFGPETAIDRSMAMSEDFVMEMGKQPIIFENPMYSARDSAVKVVQPIQVTVSENVDNKNYGSPINPSEIVPETNPTSPAADGTQVTKWNLFKRKSKQTTNFENPIYAQMENEQKESVAATPPPSPSLPAKPKPPSRRDPTPTYSATEDTFKDTANLVKEDSEV

3D Structural Models

Helix
1138..1141
Beta Strand
1111..1115; 1121..1123; 1129..1131; 1133..1136
3D Structure
Electron microscopy (1); NMR spectroscopy (1)

Domain & Motif Annotations

Compositional Bias
4565..4574; Polar residues; 4612..4624; Pro residues
Repeat
436..478; LDL-receptor class B 1; 479..521; LDL-receptor class B 2; 522..568; LDL-receptor class B 3; 569..613; LDL-receptor class B 4; 753..795; LDL-receptor class B 5; 796..837; LDL-receptor class B 6; 838..881; LDL-receptor class B 7; 882..925; LDL-receptor class B 8; 1478..1520; LDL-receptor class B 9; 1521..1563; LDL-receptor class B 10; 1566..1609; LDL-receptor class B 11; 1610..1654; LDL-receptor class B 12; 1655..1695; LDL-receptor class B 13; 1790..1832; LDL-receptor class B 14; 1833..1882; LDL-receptor class B 15; 1883..1930; LDL-receptor class B 16; 1931..1972; LDL-receptor class B 17; 1973..2013; LDL-receptor class B 18; 2107..2156; LDL-receptor class B 19; 2157..2201; LDL-receptor class B 20; 2202..2245; LDL-receptor class B 21; 2246..2289; LDL-receptor class B 22; 2431..2477; LDL-receptor class B 23; 2478..2518; LDL-receptor class B 24; 2519..2562; LDL-receptor class B 25; 2563..2604; LDL-receptor class B 26; 2605..2646; LDL-receptor class B 27; 3239..3281; LDL-receptor class B 28; 3282..3324; LDL-receptor class B 29; 3333..3376; LDL-receptor class B 30; 3377..3419; LDL-receptor class B 31; 3420..3460; LDL-receptor class B 32; 4154..4196; LDL-receptor class B 33; 4197..4240; LDL-receptor class B 34; 4242..4283; LDL-receptor class B 35
Motif
4453..4462; SH3-binding; 4456..4461; PxLPxI/L motif 1; mediates interaction with ANKRA2; 4459..4464; PxLPxI/L motif 2; mediates interaction with ANKRA2; 4521..4526; Endocytosis signal; 4595..4598; NPXY motif; 4598..4601; SH2-binding; 4611..4622; SH3-binding
Domain (CC)
Two overlapping PxLPxI/L motifs mediate interaction with ankyrin repeats of ANKRA2..; DOMAIN: The cytoplasmic domain is required for sorting to the apical cell membrane.
Domain (FT)
27..63; LDL-receptor class A 1; 66..104; LDL-receptor class A 2; 107..143; LDL-receptor class A 3; 146..180; LDL-receptor class A 4; 182..218; LDL-receptor class A 5; 221..257; LDL-receptor class A 6; 265..308; LDL-receptor class A 7; 1025..1061; LDL-receptor class A 8; 1066..1102; LDL-receptor class A 9; 1108..1144; LDL-receptor class A 10; 1148..1184; LDL-receptor class A 11; 1186..1223; LDL-receptor class A 12; 1229..1267; LDL-receptor class A 13; 1270..1306; LDL-receptor class A 14; 1304..1349; LDL-receptor class A 15; 1390..1429; EGF-like 1; calcium-binding; 1700..1741; EGF-like 2; 2699..2737; LDL-receptor class A 16; 2740..2776; LDL-receptor class A 17; 2779..2818; LDL-receptor class A 18; 2821..2860; LDL-receptor class A 19; 2863..2900; LDL-receptor class A 20; 2905..2944; LDL-receptor class A 21; 2947..2989; LDL-receptor class A 22; 2992..3028; LDL-receptor class A 23; 3031..3069; LDL-receptor class A 24; 3074..3110; LDL-receptor class A 25; 3110..3151; EGF-like 3; 3152..3192; EGF-like 4; calcium-binding; 3511..3549; LDL-receptor class A 26; 3552..3590; LDL-receptor class A 27; 3593..3631; LDL-receptor class A 28; 3634..3672; LDL-receptor class A 29; 3677..3715; LDL-receptor class A 30; 3718..3755; LDL-receptor class A 31; 3758..3794; LDL-receptor class A 32; 3797..3833; LDL-receptor class A 33; 3841..3879; LDL-receptor class A 34; 3882..3921; LDL-receptor class A 35; 3927..3963; LDL-receptor class A 36; 4007..4048; EGF-like 5; calcium-binding; 4377..4411; EGF-like 6
Region
4550..4574; Disordered; 4589..4602; Interaction with DAB2; 4601..4655; Disordered
Protein Families
LDLR family
Sequence Similarities
Belongs to the LDLR family.
Clinical Relevance
Disease Involvement
DeafnessDisease variant